1.
Statistisches Bundesamt: Todesursachenstatistik2012. www.destatis.de/DE/ZahlenFakten/GesellschaftStaat/Gesundheit/Todesursachen/Tabellen/EckdatenTU.html;jsessionid=B754B03A5F3A8F2A560094D5DA534F08.cae3.
2.
Beske F: Sechs Entwicklungslinien in Gesundheit und Pflege. Analyse und Lösungsansätze. Kiel,2011.www.dggpp.de/dggpp2011/beske/Band-119.pdf.
3.
Gröhe H: «Die Bekämpfung von Krebs ist ein wichtiges Anliegen dieser Regierung». Cited from: www.bmg.bund.de/.
4.
«Mit aller Kraft gegen den Krebs». Kampagne der Deutsche Krebshilfe. Cited from: www.mit-allerkraft.de/ueber-die-kampagne.html.
5.
The GRADE Working Group: Grading quality of evidence and strength of recommendations. BMJ 2004;328:1490-1494.
6.
Wilson JMG, Jungner G: Principles and practice of screening for diseases (1968). Geneva, World Health Organization, 1968. whqlibdoc.who.int/php/WHO_PHP_34.pdf.
7.
SGB V § 35b. dejure.org/gesetze/SGB_V/35b.html.
8.
www.bmg.bund.de/praevention/nationaler-krebsplan/was-haben-wir-bisher-erreicht/ziel-1-inanspruchnahme-krebsfrueherkennung.html.
9.
Wegwarth O, Schwartz LM, Woloshin S, Gaissmaier W, Gigerenzer G: Do physicians understand cancer screening statistics? A national survey of primary care physicians in the United States. Ann Intern Med 2012;156:340-349.
10.
Klusendieck M, Diener J: Inanspruchnahme des qualitätsgesicherten Mammographie-Screenings - Follow-Up-Studie 2012. www.bmg.bund.de/fileadmin/dateien/Publikationen/Forschungsberichte/2012/2012_4/Abschlussbericht_Mammographie-Screening_Follow-Up_Studie_2012.pdf.
11.
Klotz L: Cancer overdiagnosis and overtreatment. Curr Opin Urol 2012;22:203-209.
12.
Esserman LJ, Thompson IM Jr, Reid B: Overdiagnosis and overtreatment in cancer: an opportunity for improvement. JAMA 2013;310:797-798.
13.
Carter HB, Partin AW, Walsh PC, Trock BJ, Veltri RW, Nelson WG, Coffey DS, Singer EA, Epstein JI: Gleason score 6 adenocarcinoma: should it be labeled as cancer? J Clin Oncol 2012;30:4294-4296.
14.
Popiolek M, Rider JR, Andrén O, Andersson SO, Holmberg L, Adami HO, Johansson JE: Natural history of early, localized prostate cancer: a final report from three decades of follow-up. Eur Urol 2013;63:428-435.
15.
Albertsen P: Editorial comment. J Urol 2000;164: 1867-1870.
2014
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or...
2014
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.